Skip to content
ClinCalc Pro
Menu
Anaesthesia / ICU Neurology B

Phenytoin Correction for Albumin / Renal Failure

Adjusts a measured total phenytoin level for hypoalbuminaemia and end-stage renal disease, giving the equivalent total level at normal albumin (therapeutic range 10–20 mg/L). A measured free phenytoin level is preferred where available.

Used in: Acute Kidney Injury

UK laboratories report albumin in g/L: 30 g/L = 3.0 g/dL.

Score interpretation

Sub-therapeutic 0–9.99

Corrected phenytoin below therapeutic range (10–20 mg/L).

→ Consider dose increase. Assess seizure control and adherence. Re-check levels after dose change.

Therapeutic Range 10–20

Corrected phenytoin within therapeutic range (10–20 mg/L).

→ Continue current dose. Regular level monitoring every 3–6 months or with dose changes.

Mildly Toxic 20.01–30

Corrected level mildly elevated. May see nystagmus at higher levels.

→ Review dose. Assess for signs of toxicity (nystagmus, ataxia, sedation). Reduce dose cautiously.

Toxic 30.01–200

Corrected level in toxic range. Risk of serious adverse effects.

→ Hold phenytoin. Assess for ataxia, diplopia, dysarthria, mental status changes. Supportive care. Consider alternative anticonvulsant.

Interpretation bands for the Phenytoin Correction. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.